Alkindi Hydrocortisone | Adrenal Insufficiency | DengYueMed

  • Generic Name/Brand Name: Hydrocortisone/Alkindi®
  • Indications: Management of adrenal insufficiency in children and infants from birth to less than 18 years old.
  • Dosage Form: Granules in capsules for opening
  • Specification: 0.5 mg, 1 mg, 2 mg, 5 mg (hydrocortisone per capsule)

Alkindi Application Scope

Alkindi® is a hydrocortisone granule formulation specifically designed for children with adrenal insufficiency.

It provides precise dosing options suitable for infants, children, and adolescents (from birth to less than 18 years old)

Alkindi Hydrocortisone
Alkindi Hydrocortisone

Alkindi Characteristics

  • Ingredients:

    • Active Ingredient: Hydrocortisone
    • Excipients: Microcrystalline cellulose, hypromellose, magnesium stearate, ethyl cellulose.
  • Properties:

    • White to off-white granules contained in a transparent, colorless hard capsule.
  • Specification:

    • Each capsule contains hydrocortisone in the following strengths:
      • 0.5 mg
      • 1 mg
      • 2 mg
      • 5 mg
  • Packaging Specification:

    • Bottles containing 50 capsules each.
  • Storage:

    • Store below 25°C.
  • Expiry Date:

    • Refer to the packaging for the expiration date.
  • Executive Standard:

    • Complies with European Medicines Agency (EMA) standards.
  • Approval Number:

    • EU/1/17/1260/001 for the 0.5 mg strength.
  • Date of Revision:

    • Last updated on 7 October 2024.
  • Manufacturer:

    • Neurocrine UK (formerly Diurnal Limited).

 

Guidelines For The Use Of Alkindi

 

  • Dosage and Administration:

    • The dosage should be individualized based on body weight and clinical response.
  • Adverse Reactions:

    • Potential side effects include changes in behavior, nausea, gastric inflammation, changes in blood potassium levels, and excess acid in the blood.
  • Contraindications:

    • Not recommended for patients with hypersensitivity to hydrocortisone or any of the excipients.
  • Precautions:

    • Use with caution in patients with infections, diabetes, hypertension, or osteoporosis.

Alkindi Interactions

Drug Interactions: May interact with CYP3A4 inhibitors and inducers, anticoagulants, and other medications.

 

Note:

  • If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
  • It is only for internal discussion among medical staff and does not serve as a basis for medication. For specific medication guidelines, please consult the attending physician.
Contact Us
Contact Form Demo